Back to today’s briefing

Story perspectives

Trump's 25% Tariffs Threaten India's Pharmaceutical Exports

2/19/2025

47 8

Summary

Story summary

President Trump's looming 25% tariffs on pharmaceuticals, automobiles, and semiconductors cast a shadow over India's economy, jeopardizing its vital pharmaceutical sector that makes up 38% of exports to the US. On February 19, stocks plummeted nearly 5%, with companies like Dr. Reddy's and Cipla bracing for potential fallout as tariffs may hit by April 2.

History

Historical Context

President Trump's proposed 25% tariffs on pharmaceuticals, automobiles, and semiconductors threaten India's economy, particularly its pharmaceutical sector, which accounts for 38% of exports to the U.S. This echoes past U.S.-India trade tensions, notably during the 2000s when India's generic drug industry faced scrutiny under the TRIPS agreement, impacting access to affordable medicines globally.

1 of 2

Story summary

President Trump's looming 25% tariffs on pharmaceuticals, automobiles, and semiconductors cast a shadow over India's economy, jeopardizing its vital pharmaceutical sector that makes up 38% of exports to the US. On February 19, stocks plummeted nearly 5%, with companies like Dr. Reddy's and Cipla bracing for potential fallout as tariffs may hit by April 2.

1 / 2